Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease
Delta-secretases are associated with Alzheimer’s disease (AD) as they cleave both amyloid precursor protein and tau. Here the authors develop a series of orally bioactive small molecule delta-secretase inhibitors and report its therapeutic effects in mouse models of AD.
Main Authors: | Zhentao Zhang, Obiamaka Obianyo, Elfriede Dall, Yuhong Du, Haian Fu, Xia Liu, Seong Su Kang, Mingke Song, Shan-Ping Yu, Chiara Cabrele, Mario Schubert, Xiaoguang Li, Jian-Zhi Wang, Hans Brandstetter, Keqiang Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms14740 |
Similar Items
-
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
by: Seong Su Kang, et al.
Published: (2020-08-01) -
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease
by: Zhi-Hao Wang, et al.
Published: (2018-05-01) -
Author Correction: C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease
by: Zhi-Hao Wang, et al.
Published: (2019-11-01) -
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
by: Zhourui Wu, et al.
Published: (2020-12-01) -
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities
by: Zhentao Zhang, et al.
Published: (2020-01-01)